Equifax Lobbied To Kill Rule Protecting Victims Of Data Breaches
The credit reporting company that exposed 143 million people's private data to hackers has lobbied for the right to block consumers from suing.
Texas Chemical Plant Sued For Millions, First Responders Charge Gross Negligence
Seven members of local law enforcement and the fire department who responded to explosions at an Arkema chemical plant in the Houston area are suing the company, alleging that it failed to properly inform them of the dangers of toxic fumes they faced.
Oil Companies Leaking Benzene Lobbied Against Pollution Rules
Owners of refineries that reported leaking a cancer-causing compound into Houston's air lobbied against the EPA's refinery rule.
Dangerous Hurricane Nears Florida, State Led By Climate-Change Deniers
Hurricane Irma closes in on the coast of Florida — a state where officials banned the terms “climate change,” “global warming” and “sea-level rise.”
-
Silicon Valley Is Harming Workers And Creating More Economic Inequality, Says Expert
-
For Years, Chemical Industry Has Pressured Government To Defund Key Chemical Incident Database
-
While Lobbying Against Safety Rules, Arkema Warned Its Investors Of Chemical Storage Explosion Risks
-
Texas Chemical Plant Company Has Industry Ally Writing Rules At The EPA
More news
Court Rejects Environmental Groups' Attempt To Block EPA’s Delay Of Chemicals Rule
As responders dealt with the crisis at the Arkema chemical plant in Texas, the Washington D.C. Circuit Court denied environmental groups' attempts to keep the EPA from delaying a rule on chemical disclosures and emergency preparedness.
Texas Republicans Helped Chemical Plant That Exploded Lobby Against Safety Rules
Arkema, the company that owns a Texas chemical plant that spewed “noxious” smoke Thursday, successfully lobbied to delay the enactment of plant safety rules — regulations that would've gone into effect five months ago.
Five Ways Trump Could Make Future Natural Disasters Harder To Manage
Hurricane Harvey put President Trump’s policy choices and budget cuts in the eye of the storm, says a report from Capital & Main.
Climate Activist: Harvey Could Prompt GOP Push For More Fossil Fuel Drilling
"Shock Doctrine" author Naomi Klein says Republicans may try to turn the Houston flood disaster into a rationale for expanding fossil fuel development.
How Big Pharma Secretly Funds The Fight To Keep Drug Prices High
Big Pharma's primary trade association created a "ghost corporation" to spend millions of dollars — from hidden corporate donors —
against an Ohio ballot measure aimed at lowering drug costs.
GOP Senator Says Environmental, Health, Safety Regulations Are Pushed By 'Special Interests'
Sen. Cory Gardner, the beneficiary of fossil fuel cash, criticized Colorado towns for trying to restrict oil and gas development in residential neighborhoods.
Trump Administration Ethics Entanglements: 9 Officials Getting Lobbied By Previous Employers
The Trump White House let an Obama-era ethics rule lapse. As a result, at least nine administration officials oversee offices that are the target of lobbying efforts by companies they recently worked for.
What Can Trump Learn From Local Governments? How Not To Handle Infrastructure
Chicago's parking meters, Texas' State Highway 130, Virginia's Elizabeth River tunnels — where did they go wrong? Hint: The devil is in the (contractual) details.
How Undercover Activists Cost Breitbart, White Nationalist Sites, Their Advertising And Platforms
After the deadly white nationalist rally in Charlottesville, companies are severing ties with racist and anti-Semitic websites, removing their ads or online infrastructure.
If Trump Wants To Start Nuclear War, Can Anyone Stop Him?
Within four minutes, the president can launch nuclear weapons from a “Denny’s menu of nuclear war” and there are no checks on that authority.
Who Is Lobbying Mike Pence And Why? Health Insurers and Big Oil Seek To Influence Vice President
Vice President Mike Pence has been directly lobbied by major health care and drug companies, Wall Street firms, oil and gas interests and industry groups interested in shaping a federal infrastructure privatization initiative.
Gary Cohn's NEC Has Been Lobbied By Goldman Sachs-Backed Industry Groups
The White House said National Economic Council Director Gary Cohn would recuse himself from matters directly affecting his old employer, Goldman Sachs. But groups Goldman is a member of have been directly lobbying the NEC.
Police Body Camera Company, Axon, Is Vacuuming In Data, Stoking Privacy Concerns
Axon is using body cameras to build an artificial intelligence system that raises big civil liberties questions.
Companies Linked To Mike Pence Seek An Upper Hand In Infrastructure Policy
Dozens of firms, many of them foreign, are hiring lobbyists to get an edge over rivals when it comes to the White House's infrastructure plans. Several of them have prior connections to the officials they're lobbying.
Why Are Drug Prices So High? These Politicians Might Have The Answer
At various levels of government — federal agency leaders, state offices, Congress — individuals have taken steps to protect the pharmaceutical industry at the expense of sick consumers.
DeVos Has Invested Millions Into Company Claiming To Treat ADHD, Autism
While serving as education secretary, DeVos has continued to invest in a company accused of making misleading claims about its ability to treat ADHD and autism.
Erik Prince’s Afghanistan Plan Could Boost His Company — And China
The Blackwater founder is trying to sell the Trump administration on a plan to privatize the U.S. war effort in Afghanistan — an approach that could benefit his current company, a security contractor aligned with the Chinese government.
If Pence Shapes Trump’s Infrastructure Plan, Who Would Profit? Who Would Pay?
Mike Pence’s handling of privatization deals for Indiana roads reveals how the vice president might shape the administration’s $1 trillion plan to rebuild America. Who would profit, and who would pay?
Shareholders Can’t Force Pharmaceutical Company To Prove Drugs Aren’t Used For Executions
New York’s $192 billion pension fund put forward a shareholder resolution that would’ve forced Cardinal Health to demonstrate that its products weren’t being used in lethal injections. Regulators stood in the way.
Bernie Sanders Tells Big Pharma: Stop Making Americans Pay Twice
Drug manufacturers use U.S. tax dollars for research and then charge the world’s highest prices to U.S. consumers. Sanders and King — the two senators who don’t belong to either party — have introduced a mechanism to block them.
How Changing Corporate Tax Rates Affects The Economy, Government Revenue
Adjustments to the corporate income tax rate have little impact on how much companies actually pay, says a new study: Closing loopholes matters more.
Both Sides Of Climate Change Debate Distort Science, Block Solutions, Expert Says
Renowned climatologist Michael Mann says market mechanisms worked well in addressing environmental problems — until players like the Koch brothers made climate change a partisan issue.
Will Colorado’s Health Insurance Industry Run One Of Its Own For Governor?
As the Democratic party battles over single-payer health care, Lt. Gov. Donna Lynne, a former Kaiser Permanente exec, may enter the party’s race for governor of Colorado.
Mitch McConnell’s Super PAC Raises, Spends, Big For Alabama Senate Race
The super PAC affiliated with Mitch McConnell is pouring cash from the finance and fossil fuel industries into a Senate Republican primary race in Alabama, backing candidate Luther Strange.
What’s Not To Like About The Foxconn Deal? Criticism From Both Sides
Corporate handout? Government interference in the market? As Wisconsin holds its first public hearing on the $3 billion Foxconn deal, both liberal and conservative analysts expressed objections.
Corporate Cash Could Help Republicans Keep Control Of State Governments, Influence Redistricting
Fossil fuel and pharmaceutical donations flooded into a super PAC that boosts state legislative elections. That could help the GOP counter the unpopularity of the Trump administration and keep control of state governments.
Why Are Drug Prices So High? The Fight Over A Price-Gouging Bill
Connecticut Gov. Dannel Malloy opposed a bill to curb drug price fraud — while insurance and pharma money poured into his governors' association and his insurance commissioner maintained a close relationship with the industry.
Democratic Governors’ Fundraising Trails Republicans, Except When It Comes To Big Pharma
The Democratic Governors Association received contributions from nearly two dozen pharmaceutical companies in the first half of 2017, including some that are being sued by states for their alleged role in the opioid epidemic.
Bernie Sanders’ Drug Price Bill Would Save Billions, Congressional Analysts Say
A new Congressional Budget Office analysis shows that a bill introduced by Sanders and Senate Democrats allowing foreign drug imports would save the federal government $6 billion. But other Democrats aren't onboard.
Foxconn Deal Lets Company Ignore Wisconsin Environmental Protection Laws
Gov. Scott Walker’s deal gives Foxconn — which admitted dumping chemicals in a Chinese river — an exemption from statutes that protect Wisconsin wetlands.
Pages
- Prev
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- Next
- Promoted in Opinion
- 1
- 2
- 3
- 4
- 5
Editor's pick
-
Yields Stopped Soaring On Wednesday. Stocks Broke a Losing Streak And Climbed.
-
Investors In The Stock Market Should Expect Lower Returns Over The Next Months, Top Bank Strategist Says
-
Palantir CEO Is Betting on The War Tech Of Ukraine's Ousted Defense Minister
-
Beyond the QR Code: Why Cannabis Verification Is Emerging as an Industry Practice
-
Trump Wants The World To Follow America's AI Playbook. His Own Team Is Still Fighting Over It.
-
Two Democrats Joined Republicans In a Vote. Party Leaders Are Up In Arms.
